I’ll refine this a bit (see preliminary graphic at right) — with some actual EPS and global sales revenue guesses at some point — but since Pfizer’s Q2 2013 results press release is also on Tuesday morning, I can’t really cheat by looking at what Pfizer turns in.
Yes, Merck will be reporting at nearly the same time.
In any event, see the “Kentucky windage” I’ve thus far gleaned — solely from reading J&J’s Q2 release a few weeks back.
Most Wall Street analysts expect an “in-line” quarter, when Merck reports on Tuesday morning. Do tune in.